HGS Spin-off Licenses Technology from Parent Company

By Business Review Editor

Pharma Deals Review: Vol 2006 Issue 73 (Table of Contents)

Published: 6 Jul-2006

DOI: 10.3833/pdr.v2006.i73.490     ISSN: 1756-7874

Section: Licensing

Fulltext:

Abstract

Human Genome Sciences (HGS) granted CoGenesys (a spin-off company of HGS) the exclusive rights to develop and commercialize biological products against human gene targets identified by HGS...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details